Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc R Gastonguay

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|July 15, 2003
Population pharmacokinetics of ciprofloxacin in pediatric patientsPrabhu Rajagopalan, Marc R Gastonguay
Critical Reviews in Biomedical Engineering|May 13, 2003
Model-based approaches to biomarker discovery and evaluation: a multidisciplinary integrated reviewPaolo Vicini, Marc R Gastonguay, David M Foster
The AAPS Journal|October 10, 2006
Development and evaluation of a population pharmacokinetic-pharmacodynamic model of darbepoetin alfa in patients with nonmyeloid malignancies undergoing multicycle chemotherapyBalaji Agoram, Anne C Heatherington, Marc R Gastonguay
Journal of Pharmacokinetics and Pharmacodynamics|January 22, 2020
Latent process model of the 6-minute walk test in Duchenne muscular dystrophy : A Bayesian approach to quantifying rare disease progressionJanelle L Lennie, John T Mondick, Marc R Gastonguay
Journal of Clinical Pharmacology|January 11, 2012
Multiscale physiology-based modeling of mineral bone disorder in patients with impaired kidney functionMatthew M Riggs, Mark C Peterson, Marc R Gastonguay
The AAPS Journal|June 17, 2015
A Priori Identifiability of Target-Mediated Drug Disposition Models and ApproximationsRena J Eudy, Matthew M Riggs, Marc R Gastonguay
Plos One|April 28, 2022
Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophyJanelle L Lennie, John T Mondick, Marc R Gastonguay
Clinical Pharmacokinetics|March 1, 2015
Population Pharmacokinetic Modeling of Guanfacine in Pediatric PatientsWilliam Knebel, Mary Corcoran, James Ermer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 4, 2017
Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokineticsAlanna S Ocampo-Pelland, Marc R Gastonguay, Matthew M Riggs
British Journal of Clinical Pharmacology|November 18, 2009
Population pharmacokinetic analysis of varenicline in adult smokersPatanjali Ravva, Marc R Gastonguay, Thomas G Tensfeldt, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|July 15, 2003
Population pharmacokinetics of ciprofloxacin in pediatric patientsPrabhu Rajagopalan, Marc R Gastonguay
Critical Reviews in Biomedical Engineering|May 13, 2003
Model-based approaches to biomarker discovery and evaluation: a multidisciplinary integrated reviewPaolo Vicini, Marc R Gastonguay, David M Foster
The AAPS Journal|October 10, 2006
Development and evaluation of a population pharmacokinetic-pharmacodynamic model of darbepoetin alfa in patients with nonmyeloid malignancies undergoing multicycle chemotherapyBalaji Agoram, Anne C Heatherington, Marc R Gastonguay
Journal of Pharmacokinetics and Pharmacodynamics|January 22, 2020
Latent process model of the 6-minute walk test in Duchenne muscular dystrophy : A Bayesian approach to quantifying rare disease progressionJanelle L Lennie, John T Mondick, Marc R Gastonguay
Journal of Clinical Pharmacology|January 11, 2012
Multiscale physiology-based modeling of mineral bone disorder in patients with impaired kidney functionMatthew M Riggs, Mark C Peterson, Marc R Gastonguay
The AAPS Journal|June 17, 2015
A Priori Identifiability of Target-Mediated Drug Disposition Models and ApproximationsRena J Eudy, Matthew M Riggs, Marc R Gastonguay
Plos One|April 28, 2022
Bayesian modeling and simulation to inform rare disease drug development early decision-making: Application to Duchenne muscular dystrophyJanelle L Lennie, John T Mondick, Marc R Gastonguay
Clinical Pharmacokinetics|March 1, 2015
Population Pharmacokinetic Modeling of Guanfacine in Pediatric PatientsWilliam Knebel, Mary Corcoran, James Ermer, et al.
Journal of Pharmacokinetics and Pharmacodynamics|May 4, 2017
Model-based meta-analysis for comparing Vitamin D2 and D3 parent-metabolite pharmacokineticsAlanna S Ocampo-Pelland, Marc R Gastonguay, Matthew M Riggs
British Journal of Clinical Pharmacology|November 18, 2009
Population pharmacokinetic analysis of varenicline in adult smokersPatanjali Ravva, Marc R Gastonguay, Thomas G Tensfeldt, et al.
Pageof 6